USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sunshine LAKE Pharma Co., Ltd.

USPTO PatentsView assignee record - 107 granted patents across 22 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07D (HETEROCYCLIC COMPOUNDS).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

107

Total patents granted

CPC technology areas

17.6

Avg claims per patent

-38%

5-year filing velocity

The verdict

Sunshine holds 107 US patents across 22 technology areas, rank #3,460 of 50,000 tracked assignees.

#3,460
of 50,000 US assignees by volume: Top 19%
by Innovation Score (47.1/100): 17.6
avg claims per patent: -38%
filing velocity, last 5 yrs

Portfolio overview

Sunshine LAKE Pharma Co., Ltd. has been granted 107 US utility patents between 2015 and 2025, placing Sunshine LAKE Pharma Co., Ltd. at rank #3,460 across all assignees tracked by PlainPatent. This portfolio spans 22 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.6 claims per patent with primary concentration in C07D (HETEROCYCLIC COMPOUNDS). As a Foreign Corporation, Sunshine LAKE Pharma Co., Ltd. is one of the more focused assignees in the PatentsView dataset. By volume, Sunshine sits between Ohio University (107 patents, rank #3,456) and WMS Gaming, Inc. (107 patents, rank #3,464) - the closest US assignees by grant volume. The composite Innovation Score of 47.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 41 grants, compared with 66 in the 2015–2019 window, a -38% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Sunshine LAKE Pharma Co., Ltd.'s 17.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 22 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sunshine LAKE Pharma Co., Ltd. against peers pursuing similar technology classes.

Ohio University

107
Persimmon

107
Reckitt Benckiser…

107
Sacmi Cooperativa…

107
THE Catholic Univ…

107
THE Conard PYLE

107
Vizio

107
WMS Gaming

107
Sunshine LAKE Pha… ◀

107

What this shows Sunshine holds 107 patents at rank #3,460, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sunshine

By rank, the assignees closest to #3,460 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Sunshine's primary technology class.

Sunshine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sunshine LAKE Pharma Co., Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	5.6%
2016	17	15.9%
2017	19	17.8%
2018	12	11.2%
2019	12	11.2%
2020	6	5.6%
2021	12	11.2%
2022	12	11.2%
2023	1	0.9%
2024	4	3.7%
2025	6	5.6%

Which technologies does Sunshine LAKE Pharma Co., Ltd. patent most?

C07D - HETEROCYCLIC COMPOUNDS 95

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 90

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 84

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 10

C07F - ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM 7

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 6

C07B - GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR 6

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 4

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 4

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 3

C07K - PEPTIDES 3

C03C - CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS 2

F21V - FUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR 1

F21Y - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES F21K, F21L, F21S and F21V, RELATING TO THE FORM OR THE KIND OF THE LIGHT SOURCES OR OF THE COLOUR OF THE LIGHT EMITTED 1

A01M - CATCHING, TRAPPING OR SCARING OF ANIMALS ; APPARATUS FOR THE DESTRUCTION OF NOXIOUS ANIMALS OR NOXIOUS PLANTS 1

Top 15 of 22 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#3,460

Across all tracked assignees

Innovation Score

47.1 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Sunshine LAKE Pharma Co., Ltd. hold?

Sunshine LAKE Pharma Co., Ltd. holds 107 US granted patents filed between 2015 and 2025, spanning 22 technology areas.

What is Sunshine LAKE Pharma Co., Ltd.'s Innovation Score?

Sunshine LAKE Pharma Co., Ltd. has an Innovation Score of 47.1 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sunshine LAKE Pharma Co., Ltd. focus on?

Sunshine LAKE Pharma Co., Ltd.'s top technology area is C07D (HETEROCYCLIC COMPOUNDS) with 95 patents. The company has filed patents in 22 CPC subclasses total.

Is Sunshine LAKE Pharma Co., Ltd.'s patent filing rate increasing or decreasing?

Sunshine LAKE Pharma Co., Ltd.'s recent filing velocity is -38% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Sunshine LAKE Pharma Co., Ltd.'s patents?

Sunshine LAKE Pharma Co., Ltd.'s patents average 17.6 claims each. This falls within the standard range, providing solid legal coverage.

How is the Sunshine LAKE Pharma Co., Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Sunshine's 107 grants land it in the top 19% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Sunshine ranks #3,460 of 50,000. Top 50 holders
Most of this portfolio concentrates in C07D - see who else leads that technology area. C07D leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.